专题:Schizophrenia research and treatment

This cluster of papers focuses on the research, treatment, and various aspects of schizophrenia, including the effectiveness of antipsychotic drugs, neurocognitive deficits, genetic association studies, metabolic syndrome, neurodevelopmental models, cognitive therapy, social cognition, prodromal symptoms, dopamine dysfunction, and neuroanatomical abnormalities in individuals with schizophrenia.
最新文献
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial

article Full Text OpenAlex

Premature aging in serious mental illness

article Full Text OpenAlex

Social inclusion of people with severe mental illness: a review of current practices, evidence and unmet needs, and future directions

article Full Text OpenAlex

C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?

article Full Text OpenAlex

Prescribing clozapine to 10% of patients with schizophrenia may save 320,000 lives and cost 2400 deaths from agranulocytosis

article Full Text OpenAlex

Clozapine and Suicide in VigiBase

article Full Text OpenAlex

Helping people to discontinue antipsychotics: if, when and how

review Full Text OpenAlex

Moving beyond diagnostic labels in psychiatry: outcome-linked treatment modelling

article Full Text OpenAlex

Medication and atypical brain maturation in psychosis associated with long-term cognitive decline and symptom progression

article Full Text OpenAlex

Mapping the genetic landscape across 14 psychiatric disorders

article Full Text OpenAlex

近5年高被引文献